<DOC>
	<DOCNO>NCT02715154</DOCNO>
	<brief_summary>Current cesarean section often choose spinal anesthesia . And order avoid impact drug fetus , delivery , anesthesiologist generally n't use sedative analgesic drug . However , majority puerpera would appear nervous , anxiety , fear psychological reaction cesarean section . Although placental transfer foetal metabolism dexmedetomidine report result show adverse effect neonate , placental transfer dexmedetomidine intravertebral anesthesia area lack systematical research . This study intend use dexmedetomidine cesarean section epidural anesthesia investigate effect parturients ' haemodynamics neonate ' placental transfer metabolism .</brief_summary>
	<brief_title>Dexmedetomidine Cesarean Section</brief_title>
	<detailed_description>Current cesarean section domestic overseas often choose spinal anesthesia . And order avoid impact drug fetus , delivery , anesthesiologist generally n't use sedative analgesic drug . However , majority puerpera would appear nervous , anxiety , fear psychological reaction cesarean section , thus produce series stress reaction cause hemodynamic fluctuating anesthesia operation , also lead different degree personality behavior change . It cause serious injury physical mental health patient . Dexmedetomidine highly selective α2 receptor agonist ( α2-AR ) ，it sedation , analgesia , antisympathetic pharmacological effect unique `` conscious sedation '' without respiratory depression . At present , dexmedetomidine widely use patient clinic clinical anesthesia , hail '' dvocate medicine modern comfortable anesthesia . `` Experiments animal show dexmedetomidine adverse effect pregnant rat . In addition , Dexmedetomidine successful application preterm infant , infant child anesthesia , also caesarean patient sedation report . Although placental transfer foetal metabolism dexmedetomidine report result show adverse effect neonate , placental transfer dexmedetomidine intravertebral anesthesia area lack systematical research . The safety use dexmedetomidine neonatal outcome important issue . Experimental study acute exposure rat dexmedetomidine anticipate delivery time record absence adverse effect perinatal morphology pup , birth weight , crown-rump length , physical growth postnatal behavioural performance . Others study transfer clonidine dexmedetomidine across isolate perfused human placenta . Dexmedetomidine disappear faster clonidine maternal circulation , even less dexmedetomidine transport fetal circulation . This due great placental tissue retention , basis probably higher lipophilicity dexmedetomidine . Umbilical cord blood gas analysis umbilical vein umbilical artery study similar result previous study . The partial oxygen pressure ( PO2 ) arterial blood gas umbilical vein significantly affect oxygen supply newborn infant . On hand , umbilical arterial blood gas reliable indicator oxygenation index acid-base status fetus . Previous study indicate relationship hydrogen ion concentration ( PH ) , base excess（BE） neonatal asphyxia relatively large , positively related growth . Previous research vitro placental perfusion indicate transfer rate dexmedetomidine placenta foetus 0.77 , study indicate rate placental transfer dexmedetomidine cesarean section operation general anesthesia 0.76 . It 's indicated dexmedetomidine also easily pass placental barrier like anaesthetic drug . However , placental transfer rate dexmedetomidine much low clonidine ( 0.85 ) remifentanil ( 0.88 ) , may cause dexmedetomidine fat-soluble easier retain placenta . Recently , publish interested case report successful use dexmedetomidine 1 µg/kg follow 1 µg/kg/h 10 minute cesarean delivery facilitate awake fiberoptic endotracheal intubation patient spinal muscular atrophy type III provide adequate sedation , without respiratory compromise . Although pharmacokinetic data determine , case confirm exist vitro data dexmedetomidine significant placental transfer . Nevertheless , serious neonatal effect detect . Similarly , others use , i.v . dexmedetomidine successfully adjunct opioid-based PCA general anesthesia respective provision labor analgesia cesarean delivery anesthesia parturient tether spinal cord , favourable maternal neonatal outcome . Project Objectives : The investigator hypothesize application dexmedetomidine cesarean section epidural anesthesia conducive maintain stability hemodynamics patient , reduce patient ' anxiety pain stress operation , also adverse effect newborn . The aims present study : Our research effort focus identify effect 0.5 µg/kg/h dexmedetomidine uncomplicated cesarean delivery following . Hemodynamic [ heart rate , systolic mean blood pressure ] change . The rate placental transfer dexmedetomidine . Apgar score ( 1 5 minute ) delivery . The umbilical cord venous arterial blood gas analyse . The sedation Dexmedetomidine . The incidence major complication ( respiratory , cardiovascular event , nausea , vomit adverse reaction ) . Project Design : Study Design : The study approve first affiliate hospital ethic committee Nanjing Medical University , puerperas family sign informed consent . Sampling Site : I . Patient Selection : patient age 23-41 year ( ASA physical status I-II ) schedule elective 40 woman ( American Society Anesthesiologists [ ASA ] I II ) , uncomplicated , singleton pregnancy , receive epidural anesthesia . The investigator exclude woman history cardiac , liver , kidney disease ; allergy amide local anesthetic ; epilepsy ; take cardiovascular medication ; pregnancy-induced hypertension , evidence intrauterine growth restriction , fetal compromise . II . Anesthesia method Routine monitoring electrocardiogram ( ECG ) , heart rate ( HR ) , saturation pulse oxygen ( SpO2 ) monitor patient arrived operation room . Selected forearm vein open venous access , infused sodium lactate Ringer 's solution anaesthesia . Then begin epidural anesthesia : The patient leave side lie position , L2,3 gap chosen puncture . After determined success puncture , inserted epidural catheter head side , length epidural space 4cm . By intraductal injection 2 % lidocaine 3ml , sign spinal anesthesia exclude . Additional 0.75 % ropivacaine 10 ~ 20ml inject control level pain disappear thoracic4 ( T4 ) thoracic6 ( T6 ) satisfy operation need . After level anesthesia complete , Dex group : dexmedetomidine continuously infuse 0.5 μg/kg 10 min , follow 0.5 μg/kg/hr continuous infusion closure abdominal . normal saline ( NS ) group : Pumped volume normal saline . In operation , blood pressure low 70 % anesthesia give ephedrine 10 ~ 15mg , 0.5mg atropine use heart rate lower 60 beat per minute . All operation perform group maieutologists . III . The Investigators involve subsequent postoperative patient assessment blind patient group . IV . Observational information Systolic pressure ( SBP ) diastolic blood pressure ( DBP ) , heart rate ( HR ) record four time point : anesthesia ( T0 ) , infuse 10 min ( T1 ) , delivery baby ( T2 ) , end operation ( T3 ) . Ramsay sedation scale evaluate three time point : anesthesia ( T0 ) , skin incision ( T1 ) 10min delivery ( T2 ) . ( Ramsay standard evaluation : 1 point : anxious restless ; 2 point : cooperative , orientated tranquil ; 3 point : responding command ; 4 point : brisk response stimulus ; 5 point : sluggish response stimulus ; 6 point : response stimulus . The Apgar score evaluate 1 5 minute delivery . The urinary volume , bleed volume infusion volume operation measure . Adverse effect nausea vomit 24 hour operation record . Postoperative analgesic formula : 12mg butorphanol tartrate , 9mg granisetron hydrochloride , dilute normal saline 100ml . Background dose : 2 milliliter per hour , patient control analgesia ( PCA ) : 0.5 milliliter , lock time:15 minute . V. Samples Collection Analysis For blood gas analysis plasma dexmedetomidine concentration : Maternal venous blood sample ( MV ) , umbilical artery ( UA ) umbilical vein ( UV ) collect blood gas analysis , plasma dexmedetomidine concentration . concentration point : When baby bear . 1 . Type sample : centrifuged 3500 revolution per minute 5 minute separate plasma -20℃ frozen preservation . 2 . Laboratory Analysis : High-performance liquid chromatography-mass spectrometry ( HPLC-MS/MS ) use measure plasma dexmedetomidine concentration [ concentration umbilical vein ( CUV ) , concentration umbilical artery ( CUA ) concentration maternal vein ( CMV ) ] .. VI . Statistical Analysis : The statistical analysis perform SPSS 22.0 . The measurement data show mean ± standard deviation ( x±s ) , t-test use comparison group , repeat measure analysis variance perform comparison within group ; chi-square test use comparison count data , rank-sum test use comparison level information . p &lt; 0.05 consider statistically significant . VII . Report Writing : 2 month</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>40 case fullterm puerperas single baby ASA I II , age 23 41 year old , weigh 6192 kg , without spinal canal puncture contraindication schedule caesarean section epidural anesthesia select study . woman history cardiac , liver , kidney disease ; woman allergy amide local anesthetic ; woman epilepsy ; take cardiovascular medication ; pregnancyinduced hypertension ; woman evidence intrauterine growth restriction fetal compromise .</criteria>
	<gender>Female</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>41 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Epidural Anaesthesia</keyword>
	<keyword>Cesarean Section</keyword>
	<keyword>Dexmedetomidine</keyword>
</DOC>